Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 3 150 JPY -1.38%
Market Cap: 2T JPY
Have any thoughts about
Sysmex Corp?
Write Note

Net Margin
Sysmex Corp

10.9%
Current
11%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
53.5B
/
Revenue
491.3B

Net Margin Across Competitors

Country JP
Market Cap 2T JPY
Net Margin
11%
Country US
Market Cap 205.2B USD
Net Margin
14%
Country US
Market Cap 193.1B USD
Net Margin
29%
Country US
Market Cap 148.6B USD
Net Margin
16%
Country US
Market Cap 132.9B USD
Net Margin
11%
Country IE
Market Cap 109.9B USD
Net Margin
13%
Country US
Market Cap 64.8B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 325.5B CNY
Net Margin
33%
Country US
Market Cap 42.2B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

Sysmex Corp
Glance View

Market Cap
2T JPY
Industry
Health Care

Sysmex Corporation, a global leader in healthcare and diagnostics, specializes in innovative laboratory solutions and instruments that enhance patient care and streamline clinical workflows. Established in 1968 and headquartered in Kobe, Japan, Sysmex has evolved from a domestic player to an international powerhouse, with a presence in over 190 countries. With a steadfast commitment to research and development, the company focuses on hematology, immunochemistry, and molecular diagnostics, continually pushing the boundaries of technology. Their flagship products, which include advanced analyzers and systems, empower healthcare professionals to make timely and accurate clinical decisions, ultimately improving patient outcomes across the globe. For investors, Sysmex embodies a compelling growth story in the ever-expanding healthcare market. The aging population and increasing prevalence of chronic diseases drive demand for diagnostic solutions, positioning Sysmex to capitalize on these trends. The company’s robust financial performance is evidenced by consistent revenue growth and a strong balance sheet, supported by strategic collaborations and a diverse product portfolio. With a commitment to sustainability and social responsibility, Sysmex not only prioritizes profitability but also aims to contribute positively to global health challenges. As the world increasingly relies on advanced diagnostics, Sysmex stands out as a forward-thinking investment opportunity that combines financial stability with a meaningful social impact.

Intrinsic Value
2 987.39 JPY
Overvaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
53.5B
/
Revenue
491.3B
What is the Net Margin of Sysmex Corp?

Based on Sysmex Corp's most recent financial statements, the company has Net Margin of 10.9%.